Pharmaceutical Product Information

Tecentriq® (atezolizumab)

  • Concentrate for solution for infusion (IV) 1200 mg/20 ml

  • Concentrate for solution for infusion (IV) 840 mg/14 ml

  • Solution for injection (SC) 1875 mg /15 ml

 

Should you face issues with accessing the product information, please contact us via tel:or click